INNOVADERM EST MAINTENANT INDERO.
circle

À propos de nous

Innovaderm est maintenant Indero, un CRO à double accent dédié à l’avancement des thérapies en dermatologie et en rhumatologie. Explorez notre histoire et rencontrez notre équipe de direction.

Réinventer les soins en dermatologie et en rhumatologie

Indéro adopte une approche holistique à la recherche clinique, fusionnant l’expertise en dermatologie et en rhumatologie pour offrir des solutions innovantes pour les maladies inflammatoires immunomédiées. Notre équipe dédiée aborde les complexités des études avec un accent centré sur le sujet, transformant les défis en opportunités.

Notre histoire

Indero est l’une des trois marques (Indero, Innovaderm et Clinago) travaillant ensemble pour faire progresser la recherche en dermatologie et en rhumatologie. Chaque pilier contribue de manière unique à faire avancer les maladies inflammatoires immunomédiées.

Innovaderm est notre site de recherche clinique dédié aux études pratiques de haute qualité. Équipée de l’infrastructure et des ressources essentielles pour les études en dermatologie, cette unité pose les bases d’une recherche précise et percutante.

En tant que CRO à double accent, Indero apporte des décennies d’expertise à chaque phase d’étude clinique. Spécialisée en dermatologie et en rhumatologie, notre équipe veille à ce que les études soient menées selon les normes les plus élevées, répondant aux exigences des études sur les maladies inflammatoires immunomédiées.

Clinago, notre plateforme exclusive de recrutement de patients, offre une inscription accélérée et fiable des participants pour les études en dermatologie et en rhumatologie. En tirant parti d’un vaste réseau de patients, Clinago raccourcit les délais de recrutement, aidant les commanditaires à atteindre leurs objectifs d’étude.

Nos valeurs

Chez Indero, nos valeurs alimentent notre engagement envers l’excellence en recherche clinique. Nous collaborons, en tirant parti de décennies d’expertise pour soutenir vos objectifs. Nous embrassons l’innovation, redéfinissant constamment ce qui est possible en dermatologie et en rhumatologie. Avec un accent proactif sur les clients, les sujets et les sites, nous ne faisons pas qu’avancer la science – nous avons un impact significatif sur les soins de santé. Nous priorisons le travail d’équipe transversal, agissant avec conscience et responsabilité. En favorisant un environnement sûr et collaboratif, nous permettons à notre équipe de prendre des mesures décisives. Cet engagement envers la responsabilité personnelle garantit que nous fournissons les meilleures solutions rapidement et efficacement.
circle

PLUS FORT ENSEMBLE

CULTIVEZ L’INNOVATION

EMPHASE SUR LA PREMIÈRE LIGNE

OSEZ PASSER À L’ACTION

Philanthropie

Chez Indero, nous nous consacrons à la philanthropie pour améliorer la santé et la qualité de vie des patients. Au cours des 5 dernières années, nous avons fait don de plusieurs millions de dollars à des instituts de recherche et à des universités pour l’avancement de la recherche médicale académique. Notre engagement en faveur de l’innovation et des soins aux patients fait d’Indero un lieu où des impacts significatifs sont réalisés chaque jour.

A female doctor sits at her desk and chats to an elderly female patient while looking at her test results

Rencontrez l’équipe de direction d’Indero

Rejoignez l’équipe. indero: Nous sommes tous investis.

La science percutante nécessite expertise, passion et une quête incessante d’excellence. Ensemble nous relevons les complexités des études cliniques, s’assurant que chaque étude atteigne les meilleurs résultats possibles. 

Si vous êtes prêt à contribuer à des avancées significatives en recherche clinique, nous vous voulons dans notre équipe.

Contactez-nous

Prêt à franchir la prochaine étape dans la recherche en dermatologie et en rhumatologie ? Transformons ensemble l’avenir du traitement des maladies inflammatoires immunomédiées.

Robert Bissonnette, MD, FRCPC

Executive Chairman and founder

Dr. Robert Bissonnette is the Executive Chairman and founder of Indero. Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research and the dermatology market. He has published over 270 articles and book chapters and gives lectures on various aspects of dermatology at national and international conferences. After receiving his medical degree from the University of Montreal, he completed his residency training in dermatology followed by his clinical research training at McGill University and the University of British Columbia. Dr. Bissonnette served as an associate professor of dermatology at the University of Montreal until 2004. He is regularly invited to advisory board meetings to share his expert opinion on clinical product development. Dr. Bissonnette is internationally renowned for his clinical expertise in atopic dermatitis and psoriasis.

Jeff Smith

Chief Executive Officer

Jeff Smith, CEO of Indero, brings nearly 30 years of experience in the pharmaceutical and CRO industry, having distinguished himself through exceptional leadership, strategic vision, and innovation. Jeff’s expertise spans global operations, growth management, and fostering a collaborative corporate culture. His strengths in value creation, partner management, and CRO operations have consistently driven success in his previous roles. Under Jeff’s leadership, Indero continues to expand its capabilities, advancing medical knowledge and new therapies in dermatology and rheumatology. Jeff prioritizes purpose, people, and profitability to drive high performance and organizational excellence.

Jasmina Jankicevic, MD, MSc, CCRP

Chief Medical and Scientific Officer

Dr. Jasmina Jankicevic is globally recognized as a thought leader in dermatology & medical aesthetics drug/device development. She has led clinical development in dermatology and medical aesthetics for CROs, pharma/biotech, medical device, and cosmetic companies. She has driven program strategy and implementation of 350+ clinical study protocols in 30+ indications while leading global cross-functional teams towards successful regulatory submissions, product launches, and innovative lifecycle management. As a global expert in dermatology clinical development, Dr. Jankicevic has served as advisor to multiple companies on their way to global regulatory and commercial success of innovative therapeutic solutions for common and rare skin diseases, and aesthetic disorders. Dr. Jankicevic holds Doctor of Medicine degree, Master of Medical Sciences degree, and Board-certification in Dermatology and Venereology from the University of Belgrade, Serbia. She is also a Certified Clinical Research Professional, and a trained journalist. Dr. Jankicevic is a sought-after speaker, and author of numerous articles in peer-reviewed and trade journals.

Jason Shuris

Chief Business Officer

Jason Shuris served as Indero’s Vice President of Business Development from 2018-2021. Following a short leave, he returned to Indero in August 2022 as Chief Business Officer. Jason oversees the sales and marketing activities at the organization. In addition, he plays a key role in strategy planning and execution. Jason began his career in finance, occupying different roles in the accounting departments of privately held hospitals in Boston. He then worked in the life sciences sector as the controller at several biotechnology companies before entering the CRO industry in 2011. To date, he has held various leadership positions at ophthalmology and dermatology-focused CROs. Jason holds a Master of Science in Accounting from Bentley University (MA).

Stéphane Lussier

Chief Financial Officer

Stéphane Lussier joined Indero in 2020 and is currently the Chief Financial Officer. His responsibilities include the management of external and internal accounting, financial reporting and planning and tax analysis. Stéphane has 20+ years of leadership experience in finance and operations in medium-sized and large enterprises. His previous roles include, senior director of finance for the Canadian business division of a US-based publicly traded company in the aeronautic industry. Stephane holds a bachelor’s degree in Business Administration from the Université du Québec à Montréal. He is also a Certified Public Accountant (CPA-CMA).

Anne Marie Gaulin

Executive VP, International Expansion

Anne Marie Gaulin is responsible for the creative vision and strategic plan of action for Indero’s European Expansion initiative. Based in Europe, she will develop the region’s clinical trial activities and expertise. Anne Marie joined Indero in 2009 as the director of business development. A strategic thinker, she greatly contributed to the success and growth of the company by managing sales, marketing, recruitment, operations and commercial development. Anne Marie’s sound knowledge of clinical trials in dermatology and 25+ years’ experience in the pharmaceutical industry fostered strong relationships with our clients. Prior to joining Indero, she worked in business development at Cirion Biopharma, served as an operations manager at Alcan Packaging, and occupied different roles in sales and marketing at Rhône-Poulenc Rorer (now Sanofi) and Sandoz Consumer Health, a division of Novartis.

Ina Zschocke

Executive Vice President, European Operations and Strategy

Ina Zschocke brings over 20 years of clinical research expertise in dermatology, allergology, and aesthetics. As Vice President of European Expansion at Indero, she drives strategic growth and innovation. Previously, Ina served as the head of Dermatology, Immunology, and Inflammatory Diseases, where she developed strategies for high-quality clinical trials. Known for her strategic vision and leadership in complex trials, Ina ensures excellent outcomes for emerging biopharma clients. At Indero, she continues to expand the company’s capabilities in dermatology research, demonstrating her commitment to advancing medical knowledge and new therapies through her strategic approach and dedication to excellence.

Diane Leclerc

VP, CRO Operations

Diane is a seasoned executive leader with over 25 years in clinical and project delivery within CRO, biotechnology, and biopharmaceutical sectors. As head of Project Management and Clinical Operations, she oversees Early Phase and Translational Research, Late-Phase Project Management, Clinical Trial Management, and Clinical Monitoring. Her global team spans the Americas, Europe, and Asia, showcasing her ability to lead diverse teams. Diane excels in managing complex clinical programs, fostering client partnerships, and delivering value-driven outcomes. She has expertise in all phases of clinical drug development and medical devices, with experience in various therapeutic areas. Diane holds a Nursing Sciences degree from Laval University and certifications from SOCRA and PMI. Currently pursuing an Executive MBA, she is dedicated to enhancing her strategic capabilities and driving innovation in clinical research and operations.

Pina D'Angelo

VP, Biometrics

Pina D’Angelo holds a master’s degree in Mathematics and Statistics from McGill University. She has worked in the pharmaceutical industry for over 25 years, both on the generic as well as on the innovator side. Pina has extensive experience in many therapeutic areas in clinical trials ranging from Phase 1 to 4 studies to PK/PD and bioequivalence studies. She has also served as a lecturer of statistics for at various colleges and universities in Montreal and Toronto.

Guillaume Gigon

VP, Technology and AI

Guillaume Gigon joined Indero in 2018 and is currently the Vice President of Technology and AI. Throughout his career, he has held different positions including managing director at a large CRO. Guillaume has 15+ years’ experience in the clinical trial and biomedical industries, including project management and validation. He holds a Master of Science in Biochemistry, a DESS in Information Technology and multiple certifications including Certified CSTB Tester, LSS Green Belt and Portfolio Management.

Mélanie Pomerleau

VP, Quality and Compliance

Mélanie Pomerleau joined Indero in 2018 as Director, Quality Assurance. For the past four years, she has held the position of Senior Director, Quality and Compliance. Mélanie has over 25 years of experience in the pharmaceutical industry, with a focus on clinical research. She has served as a quality assurance manager in large CROs in both Canada and the United States (Phase I and II). Additionally, she was the Head of Clinical Quality for a small-sized pharmaceutical company specialized in women’s health where she was actively involved in phase III studies and post-approval monitoring.

Yvon Leduc

VP, Human Resources

Yvon Leduc serves as the Vice President of Human Resources at Indero. His responsibilities include developing strategies, establishing programs and setting goals for the department while fostering a diverse workplace that allows employees to flourish. Yvon has 25+ years of leadership experience in human resources management. Prior to joining Indero, he was a Senior Director of Human Resources at a global pharmaceutical company. Yvon holds a bachelor’s degree in Industrial Relations from the University of Montreal. He also holds the designation of Chartered Professional in Human Resources (CPHR) from Quebec.

est maintenant

Nous sommes ravis d’annoncer qu’Innovaderm rebaptise notre division CRO pour Indero (in-dAIR-oh). Ce changement de nom reflète notre engagement continu envers l’innovation et notre expansion dans le domaine de la rhumatologie, une aire thérapeutique étroitement liée à la dermatologie. En tant que CRO à double spécialisation en dermatologie et rhumatologie, cette décision stratégique marque une étape importante pour notre organisation, et nous sommes impatients de commencer ce nouveau chapitre avec nos partenaires et clients. Innovaderm continuera à fonctionner en tant que CRU pour les études dermatologiques.

Sélection et gestion des sites

Nos relations de longue date avec des leaders d’opinion clé et des sites hautement performants, aboutissent à des processus de démarrage optimisés qui donnent des résultats solides en un minimum de temps. Dans le cadre de notre évaluation des sites, notre équipe utilise des métriques de performance passées, des projections de recrutement basées sur l’environnement concurrentiel et des enquêtes de faisabilité détaillées pour déterminer les capacités et l’intérêt d’un site pour une étude.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Recrutement de sujets

Notre équipe dédiée au recrutement de patients et à la publicité s’intègre à l’équipe d’étude pour adapter les stratégies de recrutement, personnaliser les campagnes publicitaires centrales, développer des créations publicitaires et suivre et adapter continuellement les objectifs de recrutement. Notre approche centrée sur le patient est améliorée par Clinago, notre service de recrutement technologique.

Gestion de projet

Nous orchestrons toutes les activités et livrables de l’étude, y compris le processus de sélection des sites, les négociations budgétaires et contractuelles, et l’engagement des patients, les projections d’inscription au recrutement, tout en respectant vos délais d’étude.

Gestion de projet

Nous orchestrons toutes les activités et livrables de l’étude, y compris le processus de sélection des sites, les négociations budgétaires et contractuelles, et l’engagement des patients, les projections d’inscription au recrutement, tout en respectant vos délais d’étude.